The rise in traumatic brain injuries is one of the major industry trends that is anticipated to fuel the market for memory-improving medications during the coming years. For instance, a March 2022 article on the Centres for Disease Control and Prevention (CDC) reported that there were roughly 223,135 hospitalisations for traumatic brain injury (TBI) related reasons in the United States in 2019 and 64,362 traumatic brain injury (TBI) related deaths in 2020.
“Memory Enhancement Drugs Market is expected to reach US$ 12,172.1 million by 2030 from US$ 7,912.1 in 2022; it is estimated to grow at a CAGR of 5.5%from 2023 to 2030. The report highlights trends prevailing in the global Memory Enhancement Drugs market, and drivers and hindrances pertaining to the market growth.
Request a Sample Report @ https://www.coherentmarketinsights.com/insight/request-sample/5399
Clinical trial execution in the United States was severely disrupted by the COVID-19 epidemic, having an effect on important industry stakeholders. Staff layoffs, social-distance protocols, financial losses, and worries over consumer health led to a shift in the investigative site’s capabilities. So as to accelerate drug development, sponsors, contract research organisations (CROs), and other companies have turned to virtual workplaces. According to a study published in April 2020 on the Impact of COVID-19 on Clinical Trial Sites by Medidata, a supplier of biosciences software that assists clinical research with a main focus on view of facts, investigative sites showed flexibility and ingenuity in accepting new methods to deal with the challenges posed by the pandemic, with more than half of investigative sites switching to virtual approaches to interact with patients. Further lately, follow up studies conducted in August 2020 have shown that the COVD- 19 pandemic has a prolonged influence, with over 60% claiming an average or higher level of effect on studies conducted and the beginning trials. Recruiting and enrolling patient’s particular difficulty, according to respondents.
Recently, the U.S. Food and Drug Administration (FDA) advice (released in March 2020 and amended in July 2020) stated that the impact of COVID-19 may force organisations conducting clinical trials to take into account virtual patient visits or substitute new procedures for existing protocols. As a result, there are more chances than ever for adopting remote healthcare, including performing virtual or decentralised studies, site-free clinical trials, and using other unconventional methods that don’t require in-person visits.
The COVID-19 pandemic has had a profoundly detrimental impact on the global economy on numerous levels, which is also apparent in the healthcare industry. The burgeoning market for health care research and development is expected to have a steep decline in revenues during the lockout because to the closure of production facilities, acute shortage in raw material supply, and lack of competent labour. The supply chain and industrial processes experiencing a few minor setbacks can be used to extrapolate the pandemic’s current consequences. After COVID-19, the market is expected to gradually recover, offering promising opportunities for sales in a variety of international markets the following year.
Limited Period Offer | Report Available Now at UP TO 45% off Discounted Pricing @
Single User License : https://www.coherentmarketinsights.com/promo/buynow/5399
Multi Users License : https://www.coherentmarketinsights.com/promo/buynow/5399
Corporate Users License : https://www.coherentmarketinsights.com/promo/buynow/5399
Note: Special discounted pricing is only applicable for direct purchase through website. In case of customization, discount would be subject to scope and coverage of the report.
The advantages of memory enhancement pharmaceuticals, such as better memory and alterness, are predicted to cause the world market for memory enhancement drugs to grow at a CAGR of 5.5% over the course of the forecast period. For example, a study done in Brazil found that 4.2% of 1865 students from a range of academic subjects confessed taking cognitive enhancers (CEs) in the year prior, based on a March 2021 article on the National Library of Medicine (NIH) (2020). Methylphenidate was the most widely used Cognitive Enhancers (CE), and it was not associated with the diagnosis of Attention Deficit Hyperactivity Disorder (ADHD).
Depending on Route of Administration, the Oral Route segment is anticipated to dominate the market for memory-improving medicines over the forecast period. For instance, according to a February 2021 article on Frontier Media, roughly 84% of the most popular pharmaceutical drugs are taken orally, and almost 90% of all pharmacological formulations intended for human use are, according to estimations.
Due to the rising number of Alzheimer patients, North America is anticipated to see the highest CAGR among all regions in the global market for memory enhancement pharmaceuticals during the forecast period. For instance, according to a May 2022 post on the Alzheimer Association, the number of Americans suffering from Alzheimer’s disease is rapidly increasing and impacts roughly 6 million Americans of all ages.
Top players majorly in the international memory enhancement drugs market are Taurus Laboratories Pvt. Ltd., Intas Pharmaceutical Ltd., Paradigm Healthcare, Alkem Laboratories Ltd., Novartis AG, and Allergan plc. Shire plc. Sanochemia Pharmazeutika AG, Takeda Pharmaceutical Company, UCB S.A., Pfizer Inc.
Request For Customization at: https://www.coherentmarketinsights.com/insight/request-customization/5399
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Route of Administration
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Impact Analysis
- Regulatory Scenario
- Market Trends
- Pipeline Analysis
- Key Developments
- Epidemiology
- PEST Analysis
- Market Dynamics
- Global Memory Enhancement Drugs Market– Impact of Coronavirus (COVID-19) Pandemic
- Economic Impact
- Impact on Demand and Supply
- COVID-19 Impact Assessments
- Global Memory Enhancement Drugs Market, By Drug Class, 2017-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 – 2030
- Segment Trends
- Cholinesterase Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
- Smart Drugs and Cognitive Enhancers (Nootropics)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
- Vitamins and Supplements
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
- Introduction
- Global Memory Enhancement Drugs Market, By Route of administration, 2017-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 – 2030
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
- Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
- Introduction
- Global Memory Enhancement Drugs Market, By Application, 2017-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 – 2030
- Segment Trends
- Disease treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
- Athletic performance
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
- Academic performance
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
- Others
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 – 2030
- Segment Trends
- Introduction
- Global Memory Enhancement Drugs Market, By Distribution Channel, 2017-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 – 2030
- Segment Trends
- Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
- Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
- Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
- Introduction
- Global Memory Enhancement Drugs Market, By Region, 2017-2030, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017-2030,(US$ Mn)
- North Africa
- Central Africa
- South Africa
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Pfizer Inc*
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- UCB S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Takeda Pharmaceutical Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Shire plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sanochemia Pharmazeutika AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Allergan plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- . Alkem Laboratories Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Paradigm Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Intas Pharmaceutical Ltd.,
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Taurus Laboratories Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Pfizer Inc*
- Section
- Research Methodology
- About us
About Us:
Coherent Market Insights is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Coherent Market Insights has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Coherent are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.
Contact Us :
Mr. Shah
Coherent Market Insights
533 Airport Boulevard, Suite 400,
Burlingame, CA 94010, United States.
U.S.A: +1-206-701-6702
UK: +44-020-8133-4027
JAPAN: +050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com/